2bin: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
We have solved the crystal structures of three oncogenic mutants of the, core domain of the human tumor suppressor p53. The mutations were, introduced into a stabilized variant. The cancer hot spot mutation R273H, simply removes an arginine involved in DNA binding without causing, structural distortions in neighboring residues. In contrast, the, "structural" oncogenic mutations H168R and R249S induce substantial, structural perturbation around the mutation site in the L2 and L3 loops, respectively. H168R is a specific intragenic suppressor mutation for, R249S. When both cancer mutations are combined in the same molecule, Arg(168) mimics the role of Arg(249) in wild type, and the wild type, conformation is largely restored in both loops. Our structural and, biophysical data provide compelling evidence for the mechanism of rescue, of mutant p53 by intragenic suppressor mutations and reveal features by, which proteins can adapt to deleterious mutations. | We have solved the crystal structures of three oncogenic mutants of the, core domain of the human tumor suppressor p53. The mutations were, introduced into a stabilized variant. The cancer hot spot mutation R273H, simply removes an arginine involved in DNA binding without causing, structural distortions in neighboring residues. In contrast, the, "structural" oncogenic mutations H168R and R249S induce substantial, structural perturbation around the mutation site in the L2 and L3 loops, respectively. H168R is a specific intragenic suppressor mutation for, R249S. When both cancer mutations are combined in the same molecule, Arg(168) mimics the role of Arg(249) in wild type, and the wild type, conformation is largely restored in both loops. Our structural and, biophysical data provide compelling evidence for the mechanism of rescue, of mutant p53 by intragenic suppressor mutations and reveal features by, which proteins can adapt to deleterious mutations. | ||
==Disease== | |||
Known diseases associated with this structure: Adrenal cortical carcinoma OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Breast cancer OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Colorectal cancer OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Hepatocellular carcinoma OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Histiocytoma OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Li-Fraumeni syndrome OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Multiple malignancy syndrome OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Nasopharyngeal carcinoma OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Osteosarcoma OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Pancreatic cancer OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]], Thyroid carcinoma OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=191170 191170]] | |||
==About this Structure== | ==About this Structure== | ||
| Line 35: | Line 38: | ||
[[Category: tumor suppressor]] | [[Category: tumor suppressor]] | ||
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:03:00 2007'' | ||